Updated perspectives on the challenges of managing multiple sclerosis during pregnancy

R Villaverde-González - Degenerative Neurological and …, 2022 - Taylor & Francis
Multiple sclerosis (MS) is a chronic immune-mediated, inflammatory, and degenerative
disease that is up to three times more frequent in young women. MS does not alter fertility …

Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options

Y Wang, J Wang, J Feng - Autoimmunity Reviews, 2023 - Elsevier
Multiple sclerosis (MS) is an autoimmune-mediated degenerative disease of the central
nervous system, characterized by inflammatory demyelination. It is primarily found in women …

[HTML][HTML] Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: data from an administrative claims database

MK Houtchens, NC Edwards, B Hayward… - Multiple Sclerosis and …, 2020 - Elsevier
Background: Real-world data regarding live birth rates (LBRs) and infertility in women with
multiple sclerosis (MS) are lacking. This study compared LBRs, infertility diagnoses, and …

Effect of multiple sclerosis and its treatments on male fertility: cues for future research

C Massarotti, E Sbragia, I Gazzo, S Stigliani… - Journal of Clinical …, 2021 - mdpi.com
Multiple sclerosis is a chronic disease that may lead to different types of symptoms and
disabilities. with the better quality of life and decreased disability due to early diagnosis and …

[HTML][HTML] Multiple sclerosis in pregnancy and its role in female fertility: a systematic review

R Lamaita, C Melo, C Laranjeira… - JBRA Assisted …, 2021 - ncbi.nlm.nih.gov
Multiple sclerosis (MS) is a neurological disease that typically affects young women of
reproductive age. There are still many questions and heterogeneous clinical approaches …

Pregnancy in women with multiple sclerosis in France from 2010 to 2015: Incidence, outcomes, and exposure to disease-modifying therapies

H Tillaut, A Degrémont, S Kerbrat… - Multiple Sclerosis …, 2022 - journals.sagepub.com
Background: Multiple sclerosis (MS) is usually diagnosed between 20-40 years old, when
women often plan to have children. Objective: Our objectives were to estimate pregnancy …

Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure

K Hellwig, F Duarte Caron… - Therapeutic …, 2020 - journals.sagepub.com
Background: The goal of the present cohort study was to review outcomes of patients
exposed to interferon beta-1b during pregnancy. Methods: Pregnancy cases with exposure …

Gender disparities in health resource utilization in patients with relapsing–remitting multiple sclerosis: a prospective longitudinal real-world study with more than 2000 …

D Schriefer, NH Ness, R Haase… - Therapeutic Advances …, 2020 - journals.sagepub.com
Background: For the case of multiple sclerosis, research on gender differences from a health
economics perspective has not received much attention. However, cost-of-illness analyses …

Optimizing the “Time to pregnancy” in women with multiple sclerosis: the OPTIMUS Delphi survey

L Carbone, D Landi, R Di Girolamo, P Anserini… - Frontiers in …, 2023 - frontiersin.org
Background The debate on how to manage women affected by multiple sclerosis (MS)
during reproductive age is still open, as is the issue of fertility in such patients. Main issue …

Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy

L Almouzain, F Stevenson, D Chard… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Background The decision to have children can be complex, particularly for people with
multiple sclerosis (MS). A key concern is the use of disease modifying drugs (DMDs) during …